MedTrace Logo

Retrospective Study on Clinical Results of Preimplantation Genetic Screening at Different Embryo Stage

NCT03065114 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2017-02-27

No results posted yet for this study

Summary

Preimplantational genetic screen (PGS) is tool for diagnosis of embryo chromosome abnormality before transfer. Under this tool, patients with a family history of genetic disease or special genetic disease could avoid to produce chromosomal abnormalities of the next pregnant. This study is a retrospective study, data collection from 2001 Jan. to 2015. Nov. Patients underwent PGS and data including the couples age, infertility factors, stimulation protocols, medicine records, embryo quality records and blood tests were collected in this study. Analysis the relationship between outcomes of PGS, clinical outcomes and embryo quality is performed and further to find a diagnosis reference for clinical care.

Conditions

  • Genetic Disorder
  • Fertility Disorders
  • Reproductive Disorder

Interventions

OTHER

PGS

chromosome abnormality test from PGS and relationship between embryo development

Sponsors & Collaborators

  • Yeh

    lead OTHER

Principal Investigators

  • Maw-Sheng Lee, Phd · Lee's Women Hospital

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-12-01
Primary Completion
2015-11-30
Completion
2015-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03065114 on ClinicalTrials.gov